Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
New strategy for antibodies to distort viruses discovered

New strategy for antibodies to distort viruses discovered

Anti-SARS-CoV-2 antibodies suggested to be safe to use in pregnancy

Anti-SARS-CoV-2 antibodies suggested to be safe to use in pregnancy

Identifying the spread of novel B.1.1.523 SARS-CoV-2

Identifying the spread of novel B.1.1.523 SARS-CoV-2

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

Does SARS-CoV-2 infection contribute to adrenal gland dysfunction?

Does SARS-CoV-2 infection contribute to adrenal gland dysfunction?

Success of covid antiviral pills hinges on access to speedy and accurate tests

Success of covid antiviral pills hinges on access to speedy and accurate tests

Researchers receive $22 million grant for clinical trial that aims to reduce lung transplant rejection

Researchers receive $22 million grant for clinical trial that aims to reduce lung transplant rejection

Modeling the role of antivirals in suppressing the COVID-19 pandemic

Modeling the role of antivirals in suppressing the COVID-19 pandemic

How rural communities are losing their pharmacies

How rural communities are losing their pharmacies

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

REGEN-COV shown to rapidly reduce SARS-CoV-2 viral load in hospitalized COVID-19 patients

REGEN-COV shown to rapidly reduce SARS-CoV-2 viral load in hospitalized COVID-19 patients

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

Study reveals cellular mechanism behind older adults' susceptibility to COVID-19

Study reveals cellular mechanism behind older adults' susceptibility to COVID-19

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

Ibrutinib plus standard chemotherapy effective in younger patients with diffuse large B-cell lymphoma

Ibrutinib plus standard chemotherapy effective in younger patients with diffuse large B-cell lymphoma

Study offers hope for a new therapeutic option for patients with severe asthma

Study offers hope for a new therapeutic option for patients with severe asthma

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Study finds SARS-CoV-2 infection is proportional to cell surface ACE2 levels

Study finds SARS-CoV-2 infection is proportional to cell surface ACE2 levels

Mu and C.1.2 variant spike proteins partially resistant to neutralization by vaccine-elicited antibodies

Mu and C.1.2 variant spike proteins partially resistant to neutralization by vaccine-elicited antibodies